Skip to main content
Menu

Women's health biotech building non-invasive, tissue-based diagnostics for endometriosis and cervical cancer.

Hera Biotech develops non-invasive, tissue-based diagnostics for endometriosis and cervical cancer, built for OB-GYN, fertility and drug discovery work. Its MetriDx test detects and stages endometriosis, and its HERAfem device is a point-of-care cervical cancer diagnostic. The company is led by President and CEO Somer Baburek and has offices in the USA, Mexico and Switzerland.

Details

Industry
Biotechnology and women's health diagnostics
Founded
2020
Ownership
Women led

Services

MetriDx (opens in a new tab)

Non-invasive molecular test for endometriosis detection and staging.

HERAfem (opens in a new tab)

Non-invasive, point-of-care cervical cancer diagnostic device.

Explore

Report

Send us feedback

Thoughts, ideas or something that is not working? Tell us. The page you are on is sent with your message.